passage bio inc stock price

PASSAGE BIO stock was originally listed at a price of 2220 in Feb 28 2020. Get the latest information about the Passage Bio stock price and stock performance over time.

Tokyo Vintage Travel Poster Godzilla Retro Travel Poster Vintage Airline Posters Travel Posters

View the latest Passage Bio Inc.

. Its first product candidate PBGM01 utilizes a AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal beta-galactosidase ÃŸ-gal for GM1. 213 -002 -093 359 PM 072722. Get Passage Bio Inc PASGNASDAQ real-time stock quotes news price and financial information from CNBC.

The Company is focused on developing transformative therapies for central nervous system CNS disorders. This suggests a possible upside of 6907 from the stocks current price. Stock information by Barrons.

View analysts price targets for Passage Bio or view top-rated stocks among Wall Street analysts. NASDAQ USD Post-Market. On average analysts rate Passage Bio stock as a buy.

102 rows Passage Bio Inc. On average they predict Passage Bios share price to reach 1700 in the next year. A genetic medicines company focuses on developing transformative therapies for rare monogenic central nervous system CNS diseases.

Passage Bio stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. View real-time PASG stock price and news along with industry-best analysis. Today 52-Week Range.

220 007 329 442 PM. Passage Bio Inc. About the Passage Bio Inc.

This is 25 less than the trading day before Thursday 28th Apr 2022. PASG stock price news historical charts analyst ratings and financial information from WSJ. PASG NasdaqGS - NasdaqGS Real Time Price.

Common Stock PASG Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets. PASG stock price quote with breaking news financials statistics charts and more. Stock Price Quote NASDAQ.

Higher net loss reflects Research and development increase of 34 to 1022M expense General and administrative increase from 211M to 428M expense Stock-based Compensation in RD increase from 55M to 154M expense. What was the 52-week high for Passage Bio stock. Is a clinical stage genetic medicines company.

During the day the stock fluctuated 933 from a day low at 193 to a day high of 211. Complete Passage Bio Inc. Get a real-time Passage Bio Inc.

As of 359pm ET. If you had invested in PASSAGE BIO stock at 2220 your return over the last 2 years would have been -9045 for an annualized return of -691 not including any. Jul 27 40409 PM GMT-4 USD NASDAQ Disclaimer.

The high in the last 52 weeks of Passage Bio stock was 1334. As of 2022 July 23 Saturday current price of PASG stock is 2210 and our data indicates that the asset price has been in a downtrend for the past 1 year or since its inception. According to 15 stock analysts the average 12-month stock price forecast for Passage Bio stock is 1326 which predicts an increase of 45714.

PASG Passage Bio IncStock Price Overview. Their PASG stock forecasts range from 600 to 3400. Passage Bio stock last closed at 187 down 459 from the previous day and has decreased 848 in one year.

Company profile page for Passage Bio Inc including stock price company news press releases executives board members and contact information. It has underperformed other stocks in the Biotechnology industry by 045. Basic Earnings per Share excluding Extraordinary Items decreased from -291 to -348.

Friday 29th Apr 2022 PASG stock ended at 195. Passage Bio Inc. According to the current price Passage Bio is 13758 away from the 52-week low.

See the latest Passage Bio Inc Ordinary Shares stock price NASDAQPASG related news valuation dividends and more to help you make your investing decisions. The lowest target is 202 and the highest is 357.

Jillian Michaels On Twitter